Rosalinda Santonastaso

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Polycystic Ovary Syndrome

Magnetic Resonance Imaging

Top Venues

Journal of personalized medicine

Exploration of targeted anti-tumor therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Daniele Ugo Tari, Rosalinda Santonastaso, Davide Raffaele De Lucia, Marika Santarsiere, Fabio Pinto
Breast Density Evaluation According to BI-RADS 5th Edition on Digital Breast Tomosynthesis: AI Automated Assessment Versus Human Visual Assessment. Journal of personalized medicine 13 (4) (2023)
Daniele Ugo Tari, Rosalinda Santonastaso, Davide Raffaele De Lucia, Marika Santarsiere, Fabio Pinto
Breast Density Evaluation According to BI-RADS 5th Edition on Digital Breast Tomosynthesis: AI Automated Assessment Versus Human Visual Assessment. Journal of personalized medicine 13 (4) (2023)
Daniele Ugo Tari, Davide Raffaele De Lucia, Marika Santarsiere, Rosalinda Santonastaso, Fabio Pinto
Practical Challenges of DBT-Guided VABB: Harms and Benefits, from Literature to Clinical Experience. Cancers 15 (24) (2023)
Daniele Ugo Tari, Rosalinda Santonastaso, Davide Raffaele De Lucia, Marika Santarsiere, Fabio Pinto
Breast Density Evaluation According to BI-RADS 5th Edition on Digital Breast Tomosynthesis: AI Automated Assessment Versus Human Visual Assessment. Journal of personalized medicine 13 (4) (2023)
Daniele Ugo Tari, Rosalinda Santonastaso, Davide Raffaele De Lucia, Marika Santarsiere, Fabio Pinto
Breast Density Evaluation According to BI-RADS 5th Edition on Digital Breast Tomosynthesis: AI Automated Assessment Versus Human Visual Assessment. Journal of personalized medicine 13 (4) (2023)
Daniele Ugo Tari, Davide Raffaele De Lucia, Marika Santarsiere, Rosalinda Santonastaso, Fabio Pinto
Practical Challenges of DBT-Guided VABB: Harms and Benefits, from Literature to Clinical Experience. Cancers 15 (24) (2023)
Daniele Ugo Tari, Rosalinda Santonastaso, Fabio Pinto
Consequences of the impact of COVID-19 pandemic on breast cancer at a single Italian institution. Exploration of targeted anti-tumor therapy 3 (4) (2022)